# FOSPHENYTOIN SODIUM
> **ANDA214926** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2023-10-13
## Drug
- **FDA Application Number:** ANDA214926
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSPHENYTOIN SODIUM
- **Generic name:** FOSPHENYTOIN SODIUM
- **Active ingredients:** FOSPHENYTOIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2023-10-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214926)
---
*AI Analytics · CC0 1.0*